SummitTX Capital’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
SummitTX Capital's MRNA Position: Q3 2026 in Review
SummitTX Capital opened a new position in Moderna (MRNA) in Q3 2026: 4,336 shares worth $835K. The stake represents 0.02% of the portfolio and ranks #518 among its holdings.
1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- SummitTX Capital held 4,336 shares of Moderna worth $835K as of Q3 2026.
- Moderna was a new SummitTX Capital position in Q3 2026.
- Moderna made up 0.02% of SummitTX Capital's portfolio in Q3 2026, its #518 holding.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on SummitTX Capital's 13F filing for Q3 2026, filed 16 Nov 2026.